Structural Aspects of Raf-1:Rok-alpha Interaction
Structural Aspects of Raf-1:Rok-alpha Interaction
Disciplines
Biology (75%); Chemistry (25%)
Keywords
-
Raf-1,
Rok-alpha,
Protein:Protein Interaction,
Kinase Inhibition,
Pathway Cross-Talk,
Ras and Rho signaling
In order to survive, cells must translate and integrate the signals they receive from their environment. Many intracellular enzyme cascades are activated concomitantly in the cell, and they must potentiate or antagonize each other to implement physiologically relevant outcomes. Kinases, for example, can inhibit each other by direct phosphorylation of negative regulatory residues. We have recently discovered a new paradigm of kinase regulation and pathway cross-talk mediated by protein:protein interaction, in which the regulatory domain of a modular kinase (the Ras effector Raf-1) binds to and inhibits the catalytic domain of another kinase (the RhoA effector Rok-a). Importantly, this interaction is crucial for the developments of Ras-driven epidermal tumors. We now propose to obtain detailed structural information on this interaction, with the aim of informing the design of inhibitors that would disrupt it.
In order to survive, cells must translate and integrate the signals they receive from their environment. Several intracellular enzyme cascades are activated concomitantly in the cell, and they must potentiate or antagonize each other to implement physiologically relevant outcomes. Kinases, for example, can inhibit each other by direct phosphorylation of negative regulatory residues. Many studies have implicated the Ras and Rho pathway in the control of cell proliferation, migration, and tumorigenesis. As a consequence, major efforts are being made to target the druggable nodes, that is, the kinases, using inhibitors to block pathway activation. A better understanding of kinase regulation is crucial to reach this goal. We have recently discovered a new paradigm of kinase regulation and pathway cross-talk mediated by protein:protein interaction, in which a kinase (the Ras effector Raf-1) binds to and inhibits the another kinase (the RhoA effector Rok-?). Importantly, the latter interaction is crucial for the development of Ras-driven epidermal tumors. The results of this project show that the ability of Raf-1 to phosphorylate itself is a decisive step to maintain signal flux through the Ras pathway, at the expense of the cross-talk with Rho/Rok-?.
- Universität Wien - 100%
Research Output
- 91 Citations
- 2 Publications
- 2 Scientific Awards
- 1 Fundings
-
2017
Title Deciphering the RAS/ERK pathway in vivo. DOI 10.1042/bst20160135 Type Journal Article Author Dorard C Journal Biochemical Society transactions Pages 27-36 -
2017
Title RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKa DOI 10.1126/scisignal.aai8482 Type Journal Article Author Varga A Journal Science Signaling
-
2018
Title Scientific Retreat of the Comprehensive Cancer Center Zurich Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International -
2018
Title Santander meeting Type Personally asked as a key note speaker to a conference Level of Recognition Continental/International
-
2019
Title OEAW Doc fellowship Type Fellowship Start of Funding 2019